APP-BPI inhibits Aβ42 levels by interacting with presenilin-I

Molecular Neurodegeneration

Volumn 2, Issue 1, 2007, Pages

  Chen, Yuzhi ^a,b   Bodles, Angela M ^a   McPhie, Donna L ^c   Neve, Rachael L ^c   Mrak, Robert E ^b   Griffin, W Sue T ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

EID: 34247881906     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-2-3     Document Type: Article

References (61)

1. Chow N, Korenberg JR, Chen XN, Neve RL: APP-BPI, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J Biol Chem 1996, 271(19):11339-11346.
2. Chen Y, McPhie DL, Hirschberg J, Neve RL: The amyloid precursor protein-binding protein APP-BPI drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem 2000, 275(12):8929-8935.
3. Osaka F, Kawasaki H, Aida N, Saeki M, Chiba T, Kawashima S, Tanaka K, Kato S: A new NEDD8-ligating system for cullin-4A. Genes Dev 1998, 12(15):2263-2268.
4. Hori T, Osaka F, Chiba T, Miyamoto C, Okabayashi K, Shimbara N, Kato S, Tanaka K: Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 1999, 18(48):6829-6834.
5. Wu JT, Lin HC, Hu YC, Chien CT: Neddylation and deneddylation regulate Cull and Cul3 protein accumulation. Nat Cell Biol 2005.
6. Handeli S, Weintraub H: The ts41 mutation in Chinese hamster cells leads to successive S phases in the absence of intervening G2, M, and G1. Cell 1992, 71(4):599-611.
7. Tateishi K, Omata M, Tanaka K, Chiba T: The NEDD8 system is essential for cell cycle progression and morphogenetic pathway in mice. J Cell Biol 2001, 155(4):571-579.
8. Chen Y, Liu W, McPhie DL, Hassinger L, Neve RL: APP-BPI mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. J Cell Biol 2003, 163(1):27-33.
9. Kim HJ, Kim SH, Shim SO, Park E, Kim C, Kim K, Tanouye MA, Yim J: Drosophila homolog of APP-BPI (dAPP-BPI) interacts antagonistically with APPL during Drosophila development. Cell Death Differ 2006.
10. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ: Two transmembrane aspartates in presenilin-I required for presenilin endoproteolysis and gamma-secretase activity. Nature 1999, 398(6727):513-517.
11. Yu H, Saura CA, Choi SY, Sun LD, Yang X, Handler M, Kawarabayashi T, Younkin L, Fedeles B, Wilson MA, et al.: APP processing and synaptic plasticity in presenilin-I conditional knockout mice. Neuron 2001, 31(5):713-726.
12. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B: Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2000, 2(7):461-462.
13. Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H, Ruther E, Kornhuber J, et al.: Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PSI knockout cells. J Biol Chem 2001, 276(46):42645-42657.
14. Xia X, Qian S, Soriano S, Wu Y, Fletcher AM, Wang XJ, Koo EH, Wu X, Zheng H: Loss of presenilin I is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc NatlAcad Sci USA 2001, 98(19):10863-10868.
15. Ehehalt R, Keller P, Haass C, Thiele C, Simons K: Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003, 160(1):113-123.
16. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N, Wong PC, Xu H, Thinakaran G: Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes, J Biol Chem 2004, 279(43):44945-44954.
17. Fraering PC, Ye W, Strub JM, Dolios G, LaVoie MJ, Ostaszewski BL, van Dorsselaer A, Wang R, Selkoe DJ, Wolfe MS: Purification and characterization of the human gamma-secretase complex. Biochemistry 2004, 43(30):9774-9789.
18. Capell A, Grunberg J, Pesold B, Diehlmann A, Citron M, Nixon R, Beyreuther K, Selkoe DJ, Haass C: The proteolytic fragments of the Alzheimer's disease-associated presenilin-I form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 1998, 273(6):3205-3211.
19. Xia X, Wang P, Sun X, Soriano S, Shum WK, Yamaguchi H, Trumbauer ME, Takashima A, Koo EH, Zheng H: The aspartate-257 of presenilin I is indispensable for mouse development and production of beta-amyloid peptides through beta-cateninindependent mechanisms. Proc Natl Acad Sci USA 2002, 99(13):8760-8765.
20. De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, Checler F, Annaert W, Van Broeckhoven C, De Strooper B: Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet 2001, 10(16):1665-1671.
21. Leem JY, Saura CA, Pietrzik C, Christianson J, Wanamaker C, King LT, Veselits ML, Tomita T, Gasparini L, Iwatsubo T, et al.: A role for presenilin I in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol Dis 2002, 11(1):64-82.
22. Walsh DM, Fadeeva JV, LaVoie MJ, Paliga K, Eggert S, Kimberly WT, Wasco W, Selkoe DJ: gamma-Secretase cleavage and binding to FE65 regulate the nuclear translocation of the intracellular C-terminal domain (ICD) of the APP family of proteins. Biochemistry 2003, 42(22):6664-6673.
23. Tomita T, Takikawa R, Koyama A, Morohashi Y, Takasugi N, Saido TC, Maruyama K, Iwatsubo T: C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin. J Neurosci 1999, 19(24):10627- 10634.
24. Gandy S: The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 2005, 115(5):1121- 1129.
25. Gouras GK, Almeida CG, Takahashi RH: Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 2005.
26. Tanzi RE, Bertram L: Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120(4):545-555.
27. Younkin SG: Evidence that A beta 42 is the real culprit in Alzheimer's disease. Ann Neurol 1995, 37(3):287-288.
28. Selkoe DJ: The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 1998, 8(11):447-453.
29. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, et al.: Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 2005, 47(2):191-199.
30. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J, Esselmann H, De Strooper B: Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 2006, 96(3):732-742.
31. Deng Y, Tarassishin L, Kallhoff V, Peethumnongsin E, Wu L, Li YM, Zheng H: Deletion of presenilin I hydrophilic loop sequence leads to impaired gamma-secretase activity and exacerbated amyloid pathology. J Neurosci 2006, 26(14):3845-3854.
32. Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, Corsmit E, Cruts M, Dermaut B, Wang R, Van Broeckhoven C: Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat 2006, 27(7):686-695.
33. Grimm HS, Beher D, Lichtenthaler SF, Shearman MS, Beyreuther K, Hartmann T: gamma-Secretase cleavage site specificity differs for intracellular and secretory amyloid beta, J Biol Chem 2003, 278(15):13077-13085.
34. Hecimovic S, Wang J, Dolios G, Martinez M, Wang R, Goate AM: Mutations in APP have independent effects on Abeta and CTFgamma generation. Neurobiol Dis 2004, 17(2):205-218.
35. Francis R, McGrath G, ZhangJ, Ruddy DA, Sym M, ApfeldJ, Nicoll M, Maxwell M, Hai B, Ellis MC, et al.: aph-l and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 2002, 3(1):85-97.
36. Goutte C, Tsunozaki M, Hale VA, Priess JR: APH-I is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci USA 2002, 99(2):775-779.
37. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, et al.: Nicastrin modulates presenilin-mediated notch/glp-I signal transduction and betaAPP processing. Nature 2000, 407(6800):48-54.
38. Zhou S, Zhou H, Walian PJ, Jap BK: CD 147 is a regulatory subunit of the {gamma}-secretase complex in Alzheimer's disease amyloid {beta}-peptide production. Proc Natl Acad Sci USA 2005.
39. Li Y, Wang H, Wang S, Quon D, Liu YW, Cordell B: Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc Natl Acad Sci USA 2003, 100(1):259-264.
40. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, et al.: Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 2000. 156(1):15-20.
41. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK: Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002, 161(5):1869-1879.
42. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA: Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 2004, 25(10):1263-1272.
43. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK: Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004, 24(14):3592- 3599.
44. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC: Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 2001, 125(4):489-492.
45. Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, Yankner BA: Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 2002, 33(5):677-688.
46. Mori C, Spooner ET, Wisniewsk KE, Wisniewski TM, Yamaguch H, Saido TC, Tolan DR, Selkoe DJ, Lemere CA: Intraneuronal Abeta42 accumulation in Down syndrome brain. Amyloid 2002, 9(2):88-102.
47. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39(3):409-421.
48. Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, et al.: Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol 2004, 164(4):1495-1502.
49. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al.: Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation, J Neurosci 2006, 26(40):10129-10140.
50. Echeverria V, Cuello AC: Intracellular A-beta amyloid, a sign for worse things to come? Mol Neurobiol 2002, 26(2-3):299-316.
51. Tseng BP, Kitazawa M, LaFerla FM: Amyloid beta-peptide: the inside story. Curr Alzheimer Res 2004, 1(4):231-239.
52. Chen Y, Liu W, Naumovski L, Neve RL: ASPP2 inhibits APP-BPI -mediated NEDD8 conjugation to cullin-I and decreases APP-BPI-induced cell proliferation and neuronal apoptosis. J Neurochem 2003, 85(3):801-809.
53. Pind S, Riordan JR. Williams DB: Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator, J Biol Chem 1994, 269(17):12784-12788.
54. Hay JC, Chao DS, Kuo CS, Scheller RH: Protein interactions regulating vesicle transport between the endoplasmic reticulum and Golgi apparatus in mammalian cells. Cell 1997, 89(1):149-158.
55. Kawasaki H, Taira K: Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res 2003, 31(2):700-707.
56. Miller VM, Gouvion CM, Davidson BL, Paulson HL: Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res 2004, 32(2):661-668.
57. Clark MS, Sexton TJ, McClain M, Root D, Kohen R, Neumaier JF: Overexpression of 5-HTIB receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress. J Neurosci 2002, 22(11):4550-4562.
58. Lim F, Hartley D, Starr P, Lang P, Song S, Yu L, Wang Y, Geller AI: Generation of high-titer defective HSV-I vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques 1996, 20(3):460-469.
59. Wilson CA, Doms RW, Zheng H, Lee VM: Presenilins are not required for A beta 42 production in the early secretory pathway. Nat Neurosci 2002, 5(9):849-855.
60. Dewji NN, Mukhopadhyay D, Singer SJ: An early specific cell-cell interaction occurs in the production of beta-amyloid in cell cultures. Proc Natl Acad Sci USA 2006, 103(5):1540-1545.
61. Klafki HW, Wiltfang J, Staufenbiel M: Electrophoretic separation of betaA4 peptides (1-40) and (1-42). Anal Biochem 1996, 237(1):24-29.